1 ted with inflammation in SPF-housed Apc(Min/+) ;Il10(-/-) ,
but not in Apc(Min/+) mice.
2 1, and myosin heavy chain IIa in quadriceps of control mice
but not in ATF3-KO mice.
3 fied in samples of apical plasma membrane-derived exosomes,
but not in basolateral plasma membrane exosomes from mouse co
4 However, TGF-beta induced apoptosis in normal and benign
but not in carcinoma cultures.
5 to care, hospital admission, other hospital contact, alive
but not in care, no information) after disengagement until 30
6 umor cells and immortalized TSC2-null angiomyolipoma cells,
but not in cells with intact TSC.
7 e cohorts, and increased over 1 year in Parkinson's disease
but not in controls at a single site.
8 number of draws required prior to committing to a decision,
but not in decision accuracy.
9 duces the expression of the non-canonical Wnt5a in pericyte
but not in EC cultures.
10 roliferative and pro-migratory MKL1/2 target genes in VSMCs
but not in ECs.
11 ck and final viscosities were only detected in oil samples,
but not in fatty acids.
12 Body fat, leptin, and insulin were increased in male,
but not in female, F1 WD offspring.
13 ories of negative experiences more negative in SAD patients
but not in healthy controls.
14 as urinary methionine sulfoxide were observed in Hhip (+/-)
but not in Hhip (+/+) mice.
15 ed chemoreflex drive will be enhanced only in low output HF
but not in high output HF.
16 (inositol pyrophosphatase), or kcs1Delta vip1Delta mutants
but not in ipk1Delta kcs1Delta or ddp1Delta kcs1Delta double
17 Insertion of a 9-residue hemagglutinin epitope in IS1S2,
but not in IS5S6 or in IIS5S6, prevented the co-immunoprecipi
18 observed in blood and squamous epithelial cells of smokers,
but not in lung cancer.
19 was apparent also, though less abundantly, in neutrophils,
but not in lymphocytes.
20 with CD47 preferentially occurred in dendritic cells (DCs)
but not in macrophages.
21 sociation between %5 mC and LTL in females (all ps < 0.01),
but not in males.
22 s at follow-up in univariate analysis (Log-rank P = 0.0084)
but not in multivariate analysis.
23 12 to 0.78) were lower after CRT-D than after CRT-P in +MWF
but not in -
MWF.
24 f the RAF/MEK/ERK pathway, have been reported in pulmonary,
but not in nonpulmonary, LCH cases, suggesting organ-specific
25 tus in heart failure patients with low self-reported hrQoL,
but not in patients with acceptable quality of life at the ti
26 r areas of the motor circuit during tapping in TD patients,
but not in PIGD patients.
27 ytoskeleton in prostate epithelial cells in normal tissues,
but not in prostate cancers.
28 ived 1/40th of a human dose of IPV delivered by Nanopatch,
but not in rats given 1/8th or 1/40th dose by IM injection.
29 d allodynia were present in type 1 and type 2 diabetic rats
but not in rats with type 1 diabetes receiving insulin supple
30 All of these effects of Ro 61-8048 in monkeys,
but not in rats, were reversed by pretreatment with a positiv
31 ession significantly correlated with poor prognosis in LUAD
but not in SCC.
32 re substantial in savanna grasslands and broadleaf forests,
but not in temperate and boreal needleleaf forests.
33 ts were associated with unfavorable RFS in the 1-year group
but not in the 3-year group.
34 orce decreased with gel water content in the abdominal skin
but not in the back skin.
35 ense fluorescence in distinct compartments of the protozoa,
but not in the bacterial biomass.
36 tly reduced in the stable LTx group (24 +/- 8%, P = 0.009),
but not in the BOS TxP group (53 +/- 10%, P = 0.97).
37 pment of long-term potentiation (LTP) in the CA1-subiculum,
but not in the CA3-CA1 pathway.
38 hology and prevents podocyte loss in the DGKalpha(+/+) mice
but not in the DGKalpha(-/-) mice.
39 that regulated a large number of mRNAs in the control group
but not in the exposed groups, suggesting the disruption of m
40 proportions of loss responsive neurons (p<0.05) in the STN,
but not in the GPi.
41 te in the presence of ATP and in the absence of nucleotide,
but not in the presence of ADP.
42 However, in the placebo group,
but not in the propranolol group, memory vividness significan
43 - 1.0% vs. 24.7 +/- 2.2% in vehicle-treated mice; p < 0.05)
but not in the RA CMC group (24.1 +/- 1.2%).
44 ipoprotein, and high-density lipoprotein (HDL) cholesterol,
but not in the total-to-HDL cholesterol ratio.
45 increased bleeding in patients at high risk (score >/=25),
but not in those with lower risk profiles (pinteraction=0.007
46 ction in the above optical ICSS in VgluT2-cre control mice,
but not in VgluT2-CB1 (-/-) mice.
47 lso had variable stimulatory effects in the cellular assay,
but not in vitro Sequencing analyses further demonstrated tha
48 /CD42b(+) MKs, leading to increased platelet yield in vivo,
but not in vitro.
49 agonism in the VTA decreased wheel running in standard diet
but not in WD F1 female offspring.
50 Tail bleeding time was prolonged in DREAM KO control mice,
but not in WT or DREAM bone marrow chimeric mice.